LGALS9 and type 1 diabetes mellitus: A deficiency in immune checkpoint molecules with pro-inhibitory effects, including programmed cell death ligand 1 (PD-L1) and galectin-9 (Gal-9), has been observed in pancreatic β-cells and has been linked to the progression of T1D[29].